tiprankstipranks

Akshay Vaishnaw Insider Profile

4 Followers
Akshay Vaishnaw, President, R&D at Alnylam Pharma, holds 14.63K shares in Alnylam Pharma (Ticker: ALNY), holds ― shares in Editas Medicine (Ticker: EDIT), holds ― shares in Scholar Rock Holding (Ticker: SRRK).
tipranks
Akshay Vaishnaw

Akshay Vaishnaw
Alnylam Pharma (ALNY)
President, R&D

Not Ranked
Akshay Vaishnaw has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
0.00%
0.00%
A breakdown of Akshay Vaishnaw's holdings

Insider Roles

Alnylam Pharma
(ALNY)
President, R&D
Editas Medicine
(EDIT)
Director
Scholar Rock Holding
(SRRK)
Director
Roles that Akshay Vaishnaw holds in companies

Most Profitable Insider Trade

Stock:
Alnylam Pharma
(ALNY)
Rating:Informative Buy
Date:Nov 30, 2015 - Nov 30, 2016
Return:-57.80%
The most profitable trade made by Akshay Vaishnaw

Akshay Vaishnaw's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Alnylam Pharma
Oct 01, 2020
President, R&D
Uninformative Sell
135.94K
$1.90M
Editas Medicine
Director
Scholar Rock Holding
Director
List of latest transactions for each holding click on a transaction to see Akshay Vaishnaw's performance on stock

Akshay Vaishnaw insider profile FAQ

What is the percentage of profitable transactions made by Akshay Vaishnaw?
The percentage of profitable transactions made by Akshay Vaishnaw is ―.
    What is the average return per transaction made by Akshay Vaishnaw?
    The average return per transaction made by Akshay Vaishnaw is ―.
      What stocks does Akshay Vaishnaw hold?
      Akshay Vaishnaw holds: ALNY, EDIT, SRRK stocks.
        What was Akshay Vaishnaw’s latest transaction?
        Akshay Vaishnaw latest transaction was an Uninformative Sell of $135.94K.
          What was Akshay Vaishnaw's most profitable transaction?
          Akshay Vaishnaw’s most profitable transaction was an Informative Buy of ALNY stock on November 30, 2015. The return on the trade was -57.80%.
            What is Akshay Vaishnaw's role in Alnylam Pharma?
            Akshay Vaishnaw's role in Alnylam Pharma is President, R&D.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.